{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "adds_modification",
    "modifications" : [ {
      "modification_type" : "phosphorylation"
    } ],
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "be:ERK",
      "entity_text" : "ERK1/2",
      "entity_type" : "family"
    },
    "is_direct" : false,
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:Q8N138",
      "entity_text" : "ORMDL3",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "The in vitro study suggested that ORMDL3 overexpression promotes ERK1/2 phosphorylation, and via SPHK1 activation and inhibition, reverses ORMDL3 induced AE barrier dysfunction by alleviating ERK1/2 phosphorylation.",
  "reading_complete" : "2020-08-02T13:45:31Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T13:44:07Z",
  "trigger" : "promotes",
  "evidence" : [ "ORMDL3 overexpression promotes ERK1/2 phosphorylation" ],
  "pmc_id" : "6605285",
  "score" : 0
}